EPHA10
Summary: Ephrin receptors, the largest subfamily of receptor tyrosine kinases (RTKs), and their ephrin ligands are important mediators of cell-cell communication regulating cell attachment, shape, and mobility in neuronal and epithelial cells (Aasheim et al., 2005 [PubMed 15777695]). See MIM 179610 for additional background on Eph receptors and ephrins.[supplied by OMIM, Mar 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
EPH receptor A10 | MIM:611123 | Ensembl:ENSG00000183317 | HGNC:HGNC:19987 | PA134938798 | 1p34.3 |
GO terms in EPHA10
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IBA | GO:0004709 | MAP kinase kinase kinase activity |
MF | IBA | GO:0004713 | protein tyrosine kinase activity |
MF | IBA | GO:0004714 | transmembrane receptor protein tyrosine kinase activity |
MF | IBA | GO:0004888 | transmembrane signaling receptor activity |
MF | IEA | GO:0005003 | ephrin receptor activity |
MF | IBA | GO:0005005 | transmembrane-ephrin receptor activity |
MF | IPI | GO:0005515 | protein binding |
MF | IEA | GO:0005524 | ATP binding |
MF | IBA | GO:0031434 | mitogen-activated protein kinase kinase binding |
CC | IEA | GO:0005576 | extracellular region |
CC | IBA | GO:0005737 | cytoplasm |
CC | TAS | GO:0005886 | plasma membrane |
CC | IBA | GO:0005887 | integral component of plasma membrane |
CC | IEA | GO:0005887 | integral component of plasma membrane |
CC | IBA | GO:0043005 | neuron projection |
CC | IBA | GO:0043235 | receptor complex |
BP | IBA | GO:0007275 | multicellular organism development |
BP | ND | GO:0008150 | biological_process |
BP | IBA | GO:0009968 | negative regulation of signal transduction |
BP | IEA | GO:0018108 | peptidyl-tyrosine phosphorylation |
BP | IBA | GO:0030154 | cell differentiation |
BP | IBA | GO:0033674 | positive regulation of kinase activity |
BP | IBA | GO:0043066 | negative regulation of apoptotic process |
BP | IBA | GO:0043410 | positive regulation of MAPK cascade |
BP | TAS | GO:0048013 | ephrin receptor signaling pathway |
BP | IBA | GO:0070374 | positive regulation of ERK1 and ERK2 cascade |
Gene expression in normal tissue: EPHA10
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in EPHA10
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-1266738 | Developmental Biology |
reactome | R-HSA-2682334 | EPH-Ephrin signaling |
reactome | R-HSA-2682334 | EPH-Ephrin signaling |
reactome | R-HSA-3928663 | EPHA-mediated growth cone collapse |
reactome | R-HSA-3928663 | EPHA-mediated growth cone collapse |
reactome | R-HSA-3928665 | EPH-ephrin mediated repulsion of cells |
reactome | R-HSA-3928665 | EPH-ephrin mediated repulsion of cells |
reactome | R-HSA-422475 | Axon guidance |
reactome | R-HSA-422475 | Axon guidance |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD511 | CHEMBL399379 | 2 |
iGMDRD886 | Compound 1541A | 3 |
iGMDRD60 | Quinoclamine | 3 |
iGMDRD351 | GW843682X | 3 |
iGMDRD61 | Kinetin riboside | 3 |
iGMDRD341 | Triacsin c | 2 |
iGMDRD286 | Nsc 632839 | 3 |
iGMDRD872 | BRD7137 | 3 |
iGMDRD483 | SCH-529074 | 1 |
iGMDRD318 | PAC-1 | 3 |
iGMDRD781 | Sirolimus | 1 |
iGMDRD6 | AM-580 | 1 |
iGMDRD150 | RITA | 1 |
iGMDRD427 | ABT737 | 4 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in EPHA10